跳至主要内容
临床试验/ACTRN12615000147583
ACTRN12615000147583已完成未知

In middle aged men with the Metabolic Syndrome, does the ingestion of palmitic acid rich fats, compared with palmitic acid poor fats, acutely affect postprandial chylomicron composition.

Auckland UniServices0 个研究点目标入组 40 人开始时间: 2015年2月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
45 Years 至 60 Years(—)
性别
Male

入选标准

  • 45-60 years old
  • BMI of 18-25 kg/m2
  • Healthy (no current or past history of the Metabolic Syndrome as defined by the International Diabetes Federation)
  • 45-60 years old
  • BMI greater than 25 kg/m2
  • Metabolic Syndrome as defined by the International Diabetes Federation: central obesity (waist circumference greater than/equal to 94cm PLUS any two of:
  • * raised TG concentrations (greater than/equal to 1.7 mmol/L or undergoing treatment)
  • * reduced HDL-C (<1.03 mmol/L or undergoing treatment)
  • * raised blood pressure (greater than/equal to 130/85 mmHg or undergoing treatment)
  • * raised fasting plasma glucose (greater than/equal to 5.6 mmol/L or previously diagnoses T2DM)

排除标准

  • History of CVD disease/complications (myocardial infarction, angina, stroke)
  • History of cancer
  • Pre-existing diabetes
  • Self reported alcohol intake exceeding a moderate intake (>28 units/week)
  • Abnormal liver function or haematology

研究者

发起方
Auckland UniServices

相似试验